Tg(Cyp21a1-Apoe)619Fet
Transgene Detail
|
Symbol: |
Tg(Cyp21a1-Apoe)619Fet |
Name: |
transgene insertion 619, Fayanne Thorngate |
MGI ID: |
MGI:3822316 |
Synonyms: |
Line 619 |
Transgene: |
Tg(Cyp21a1-Apoe)619Fet Location: unknown
|
Alliance: |
Tg(Cyp21a1-Apoe)619Fet page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Cyp21a1-Apoe)619Fet expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Note |
mouse |
Apoe (MGI:88057) |
|
|
|
|
Mutation details: A construct containing approximately 6 kb of the mouse Cyp21a1 promoter attached to the mouse Apoe gene was used for injection into fertilized FVB/N oocytes. Ten independent founder lines were generated. Line 619 was donated to the Jackson Laboratory and is representative of low expressing Apoe lines (lines 619 and 620). Only adrenal expression of Apoe was detected for these lines with Line 619 having the lowest mRNA expression (1.6 pg Apoe mRNA per microgram of total RNA). Mice have only 1-2% of wild-type plasma Apoe protein level.
(J:130658)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:130658 Thorngate FE, et al., Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1939-45 |
All: |
3 reference(s) |
|